Wed.Sep 25, 2024

article thumbnail

Sustainability in Isolation

Salon Today

According to a new survey, many beauty professionals feel shy about discussing sustainability, and unable to act in the face of perceived opposition from other owners, colleagues and guests.

article thumbnail

Capella Bangkok name the No.1 in the World’s 50 Best Hotels 2024

Spa Executive

Capella Bangkok offers panoramic views of the majestic Chao Phraya River and is a gateway to the eternal beauty of nature, and the urban oasis of the city. Bangkok has been named the No.1 Best Hotel in the World and Capella Singapore No.33 in the global ranking of The World’s 50 Best Hotels 2024. Capella Bangkok has also earned the title of The Best Hotel in Asia 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Smart Snacking for Women Over 40: Balance Blood Sugar & Boost Energy During Menopause

Alison Bladh

When we think about food, our attention often focuses on improving our main meals. But when you’re navigating the changes that come with perimenopause or menopause, it’s equally important to consider your snacks. The right snack choices can boost energy, balance blood sugar, and even support healthy weight management— all crucial for feeling your best during this stage of life.

article thumbnail

A Comprehensive Guide to Effective Marketing Strategies for Your Skincare Business

The Skin Games

Hey there, passionate esthetic business owners! thsi is aStacey Stark, Director of Marketing at Lexley Skincare and a marketing communications consultant with over two decades of experience. Today, I’m excited to dive deep into some game-changing marketing strategies that will help your small aesthetic business thrive and attract the clients you’ve always dreamed of serving.

article thumbnail

The 5 Most Expensive States for Self-Care in the U.S.

Skin Inc

To rank the most expensive cities for self-care, research conducted by Groupon found the average prices for six activities—brunch, massage, facial, iced latte, manicure and pedicure—across the 50 most populated U.S. cities.

Facials 52
article thumbnail

1

Mindbody

The Customer Referral Program makes it easy to refer friends or local businesses in your community to Mindbody and earn $$$.

52

More Trending

article thumbnail

1

Mindbody

Our latest software improvements are here! We’ve streamlined branded web capabilities, optimized your business’s branded app, and more.

article thumbnail

Get to Know Nadia Vassell: Beauty Launchpad 25 Under 50K Winner for 2024

Beauty Launchpad

Meet Nadia Vassell (@nadiavassellsalon). She is a hairstylist, entrepreneur and owner of Nadia Vassell Salon in Soho, NY.

Salon 52
article thumbnail

Featured property: Rancho Santana

Spa Executive

Set where Nicaragua’s lush tropical hills and forests meet breathtaking shorelines, Rancho Santana is an adventurer’s paradise and a wellness sanctuary. Rancho Santana is an expansive, sustainable private resort and residential community located on 2,700 acres of Nicaragua’s Emerald Coast. Affectionately referred to as “The Ranch,” the property features a range of accommodations, including spacious rooms and suites at The Inn and a collection of condo-style residences and ocean-view homes

article thumbnail

AbbVie Presents New Data on Efficacy of Upadacitinib in Moderate to Severe Atopic Dermatitis, High-Impact Areas

Dermatology Times

A new analysis from phase 3 studies shows Rinvoq's effectiveness for moderate to severe AD with head and neck involvement.

article thumbnail

Upadacitinib Performs Well in Phase 3 Trials of Hard-to-treat Head and Neck AD

The Dermatology Digest

Upadacitinib (Rinvoq, AbbVie) performed well in moderate-to-severe atopic dermatitis (AD) patients with head and neck involvement, according to a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15mg or 30mg) in patients with moderate-to-severe atopic dermatitis (AD) stratified by the severity of disease in the head and neck region at baseline compared to placebo across 16 weeks.

article thumbnail

Study Reports Long-Term Efficacy of Lebrikizumab for AD

Dermatology Times

The study found that over 80% of patients who responded to lebrikizumab at week 16 maintained clear or almost-clear skin after 3 years.

41
article thumbnail

Sun Pharma’s JAK Inhibitor Dims Anxiety and Depression Symptoms in AA

The Dermatology Digest

Alopecia areata (AA) commonly travels with anxiety and depression, and new research shows that deuruxolitinib (Leqselvi, Sun Pharma) can improve symptoms of depression and anxiety in patients with AA. The US Food and Drug Administration (FDA) approved deuruxolitinib, a Janus kinase (JAK) 1/JAK 2 inhibitor, for adults with moderate to severe AA in July 2024.

article thumbnail

Advancing Sexual Health Histories in Dermatology: A Modernized Comprehensive Approach for Diverse Populations

Dermatology Times

In recent years, there has been a noticeable rise in diagnoses of sexually transmitted infections, often which present with skin findings.

article thumbnail

Orismilast Achieves Early itch Reduction in Adults With AD

The Dermatology Digest

Orismilast demonstrated early itch reduction in adults with moderate-to-severe atopic dermatitis (AD), according to a phase 2b study presented at the 2024 European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. Orismilast is a potent selective phosphodiesterase 4 (PDE4)-B and -D inhibitor under development by Union therapeutics.

article thumbnail

Study Results Demonstrate High Secukinumab Persistence in Psoriasis Patient Population of Greece

Dermatology Times

Researchers presented interim 3-year results from the European SERENA study.

41
article thumbnail

Fall into Shape with truSculpt Body Shaping in Brunswick, Ohio

Trillium Creek Dermatology

As the crisp autumn air settles over Brunswick, Ohio, many residents are looking for ways to refine their figures before the holiday season arrives. At Trillium Creek Dermatology, we’re excited to offer a revolutionary body-shaping solution that’s perfect for the fall season: truSculpt body shaping. What is truSculpt? truSculpt is a non-invasive body contouring treatment that uses radiofrequency energy to target and eliminate stubborn fat cells.

article thumbnail

Psoriasis within the US Hispanic Population: What Can Be Done to Diversify Clinical Data?

Dermatology Times

Mona Shahriari, MD, FAAD, shared insights into prevalence, clinical presentations, increasing research diversity, and advocating for representation.

Clinic 36
article thumbnail

Seen Haircare Brand Closes $9 Million Series A Funding

The Dermatology Digest

SEEN, the haircare brand developed by dermatologist Iris Rubin, MD, just closed a $9 million Series A funding. “This marks another transformative milestone for SEEN,” says Dr. Rubin in a news release. “A majority of adults in the U.S. have self-described sensitive skin and over 100 million people in the U.S. suffer from acne, eczema, dry scalp, and hair shedding, which can be exacerbated by irritating, allergenic, and/or pore-clogging ingredients in hair products.

article thumbnail

Case-Based Insights: Managing Long-Standing Vitiligo With Extensive Depigmentation and Atopic Comorbidities

Dermatology Times

Pearl E. Grimes, MD, provides case-based insights on managing long-standing vitiligo with extensive depigmentation and atopic comorbidities, focusing on treatment history, comorbid conditions, and the impact on quality of life.

article thumbnail

Optimizing Vitiligo Stabilization and Repigmentation With Combination Therapies

Dermatology Times

Pearl E. Grimes, MD, discusses strategies for optimizing vitiligo stabilization and repigmentation through combination therapies, emphasizing long-term maintenance, treatment modalities, and the use of topical agents like tacrolimus and ruxolitinib cream.

Therapy 36
article thumbnail

Managing Long-Standing Vitiligo With Facial Involvement: Case-Based Insights Into OTC Solutions, Repigmentation, and Relapse Prevention

Dermatology Times

Pearl E. Grimes, MD, explores managing long-standing vitiligo with facial involvement, focusing on over-the-counter solutions, repigmentation strategies, and relapse prevention techniques.

Facials 36
article thumbnail

Redefining Vitiligo Management: FDA-Approved Topical Ruxolitinib and the Evolving Treatment Paradigm

Dermatology Times

Pearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.